Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors - 26/11/14
, Marcos Ballester, MD, PhD a, c, Catherine Uzan, MD, PhD d, Raffaele Fauvet, MD, PhD e, Philippe Morice, MD, PhD d, Emile Darai, MD, PhD a, cAbstract |
Objective |
Recurrence prediction is a cornerstone of patient management for borderline ovarian tumors. This study aimed to develop a nomogram predicting the recurrence probability in individual patients who had received primary surgical treatment.
Study Design |
This retrospective multicenter study included 186 patients with borderline ovarian tumor diagnosed from January 1980 through December 2008. A multivariate logistic regression analysis of selected prognostic features was performed and a nomogram to predict recurrence was constructed. The nomogram was internally validated.
Results |
The overall recurrence rate was 34.4% (64/186), with noninvasive and invasive forms in 29% (54/186) and 5.4% (10/186) of cases, respectively. International Federation of Gynecology and Obstetrics stage, age at diagnosis, histologic subtype, completeness of surgery, and type of surgery (radical vs fertility sparing) were associated with an increased risk of recurrence and were included in the nomogram. The predictive model had a concordance index of 0.78 (95% confidence interval, 0.76–0.80) and 0.77 (95% confidence interval, 0.75–0.79) before and after the 200 repetitions of bootstrap sample corrections, respectively, and showed good calibration.
Conclusion |
Our results support the use of the present nomogram based on 5 clinical and pathological characteristics to predict recurrence probability with a high concordance, hence to inform patients on surgical management. External validation is required to recommend this nomogram in routine practice.
Le texte complet de cet article est disponible en PDF.Key words : borderline ovarian tumors, conservative treatment, nomogram, recurrence, surgery
Plan
| The authors report no conflict of interest. |
|
| Cite this article as: Bendifallah S, Ballester M, Uzan C, et al. Nomogram to predict recurrence in patients with early- and advanced-stage mucinous and serous borderline ovarian tumors. Am J Obstet Gynecol 2014;211:637.e1-6. |
Vol 211 - N° 6
P. 637.e1-637.e6 - décembre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
